OCON CEO promotes intrauterine innovation – Globes
Based in Modi’in, OCON is also establishing the SEAD solution to deal with AUB (unusual uterine bleeding) with no surgery or hysterectomy, and the item is now in phase II scientific trials.
The company just recently won the Seal of Excellence for the European Commission for research study and innovation.
Leshem previously served as VP sales and business development and prior to that was VP of Dutch pharmacaeutical company VISUfarma, and CEO of Biolite Group business ViSci.